Appetite suppressants, the big hope, the big letdown
If only we
could just not want to eat. Wouldn’t that make staying healthy so much easier?
We’d eat what we needed because it was the right thing to do for our health –
like brushing our teeth – not because it was such a rewarding source of
pleasure.
No such luck.
We love food. We’re hard-wired to want it. That’s part of what assures survival
of the species, and we further cultivate our appetites for it by associating
food with every other kind of satisfying joy from birth onward – maternal
comfort, familial stability, social interaction, celebration, etc.
But enjoying
food for more than physical sustenance is part of the reason we have an obesity
crisis.
So appetite
suppressants are the most widely used of the medicines and supplements used for
weight-loss therapy. The logic is simple—if you have no appetite, you’ll eat
less and you’ll lose weight.
Having no
appetite could be a powerful defense against the world of “eat-more, eat-now”
messages that constantly bombard Americans, stimulating our appetites by any
means available.
A person who is suddenly finding it easier to pass on
the junk and the massive servings can exercise a lot more control over the
quantity and quality of their intake. And that’s just the boost some people need
to make a routine of healthy dietary changes, and that boost can sometimes come
from a medication.
But it’s no
get-out-of-weight-free card. Chemically, appetite suppressants act on the
central nervous system (CNS) to decrease appetite or cause the feeling of
fullness that doctors call satiety. But appetite suppressants are also the most
controversial because of potentially dangerous side effects.
Some appetite
suppressants are addictive, and their effect tends to wear off if used over an
extended time, such that people need to take larger doses to produce the same
result, which in turn increases the risk of addiction, which in turn increases
other risks.
Among
prescription appetite suppressants, most people remember the Fen-Phen debacle.
The combination of phentermine and fenfluramine or dexfenfluramine were
prescribed for thousands of people with weight problems in the mid-1990s.
Fen-Phen was
hailed as the new magic bullet, and there was tremendous excitement about it, as
early trials showed promising results. People also had a sense of confidence
about its safety and efficacy, because it had been through the rigors of FDA
testing.
Phentermine is
an andrenergic, which means it is activated by the body’s natural epinephrine
(adrenaline) supply or another epinephrine-like substance. Like an amphetamine,
it acts to stimulate metabolism and suppress the appetite.
Fenfluramine
and dexfenfluramine also increased serotonin levels in the brain and enhanced
the appetite suppression effects of phentermine while alleviating some of its
unpleasant stimulant effects.
Fen-Phen was
indeed effective in helping people lose weight, but it also turned out to be
associated with numerous cases of valvular heart damage. Some people died,
others were hospitalized. Even though the combination drug was subjected to
extensive testing, this was a side effect that researchers hadn’t discovered
before it was released to the public and subject to broader use.
In 1997,
fenfluramine and dexfenfluramine were withdrawn from the U.S. market, to much
objection and outcry from patients—presumably those without heart damage—who
were successfully losing weight with the help of Fen-Phen. Only phentermine
remains available.
The Fen-Phen
situation remains an oft-cited example of the very real danger of drug
interactions. Even with the rigorous testing the drug was subjected to in
controlled studies, the problem with heart trouble wasn’t detected until it was
released and began to be used by thousands of patients. Only then did the
frequency of heart problems become clear.
Another
weight-loss medication that was pulled is Phenylpropanolamine. Once sold under
prescription as Destrim, and over the counter in various weight-loss products
and cold treatments, it was removed from the market in 2000 after a large study
found that it increased the risk of hemorraghic stroke.
Sibutramine
(Meridia) was approved for weight-loss treatment in 1998, just in time to fill
the void left by Fen-Phen. Not surprisingly, an eager public seized upon it as
the new hope.
Like
fenfluramine and dexfenfluramine, sibutramine affects the function of serotonin
in the brain, though sibutramine goes about it differently, and it doesn’t
produce the adverse side effects on the heart. Sibutramine at 10 to 30 mg per
day has helped patients reduce their weight by up to 10 percent over six to 12
months, which is above average. In three studies, up to 25 percent of lost
weight was regained within one to six weeks of stopping medication, and in
another study, up to 80 percent of weight lost was regained within three months
of stopping medication.
But patients
who stay on sibutramine typically gain back less than 20 percent of the weight
lost.
And there’s
the rub! Unlike most weight-loss medications, sibutramine actually is approved
by the FDA for long-term use of more than 12 months, so patients may be able to
get a supportive regimen of medication for a longer period with
sibutramine.
But once
again, there’s no perfect safe solution. Other safety concerns about sibutramine
led to its removal from the market in Italy, and France and Great Britain are
considering similar action because of reports of heart attack, stroke,
arrhythmia, and some deaths in patients taking sibutramine, even though a clear
causal relationship hasn’t been established.
Doctors and
researchers know that sibutramine does increase blood pressure and heart rate,
but no one knows yet if it’s responsible for causing heart attack or some other
serious adverse effects. Until this is better understood, if your doctor
suggests using sibutramine, remember that diligent tracking of your blood
pressure will be essential.
And if you
already have coronary artery disease, heart failure or high blood pressure,
remember that the purpose of losing weight is to improve your health. The amount
of loss you could get from sibutramine would not justify recklessly elevating
your current risks, so you probably should not be on sibutramine at all.
THROUGH THICK & THIN
Appetite suppressants don’t alleviate the need to
change unhealthy dietary habits. You still have to learn how to
eat properly and take care of your nutritional needs. It does no
good to eat less overall, but then to ingest junky calories when
you do eat.
Caroline J. Cederquist, M.D. is a board certified Bariatric Physicians,
the medical specialty of weight management, and a board certified
Family Physician. She specializes in lifetime weight management
at the Cederquist Medical Wellness Center, her Naples, FL private
practice.
Dr. Cederquist is a contributing
medical editor for NBC-2 News, a trustee of the American Society
Of Bariatric Physicians and the author of " Helping Your Overweight
Child - A Family Guide", www.Amazon.Com or by
Calling Toll-Free 1-800-431-1579.
If you are interested in a delicious,
doctor-designed, foolproof plan for fast and healthy weight loss
please visit Dr. Cederquist's Diet-To-Your-Door program by clicking here.